FLGT Q1 2020 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q1 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$8M+44.4% YoY

Gross Profit

$4M47.7% margin

Operating Income

-$2M-24.7% margin

Net Income

-$2M-25.2% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-7.6%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

$570,000

Stock-Based Comp.

$924,000

Balance Sheet

Total Assets

$89M

Total Liabilities

$8M

Stockholders' Equity

$81M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+44.4%
Gross Profit	$4M	$2M	+53.9%
Operating Income	-$2M	-$2M	-5.0%
Net Income	-$2M	-$2M	-2.5%

Geographic Segments

UNITED STATES

$6M73%

Other Countries

$1M19%

CANADA

$619,0008%